Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results
SAN DIEGO, Apr. 10, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its first quarter 2024 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on May 1, 2024.
Corporate Presentation Link Placeholder (Available May 1, 2024 at 7:00 a.m. Eastern Time)
OPEN WEBCAST
Neurocrine Biosciences to Particpate at the UBS Virtual CNS Day 2024 Conference
Eiry Roberts, Chief Medical Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the UBS Virtual CNS Day Conference at 12:00 p.m. Eastern Time on Monday March 18, 2024.
OPEN WEBCAST
Neurocrine Biosciences to Particpate at the Stifel 2024 Virtual CNS Days Conference
Kyle Gano, Chief Business Development and Strategy Officer, and Grace Liang, Vice President of Clinical Development, will present at the Stifel 2024 Virtual CNS Days Conference at 2:00 p.m. Eastern Time on Tuesday March 19, 2024.